Nasdaq
BLRX
BioLineRx Ltd.
- Health Care
- Israel
- 1 day
- +2.7%
- 1 month
- −11.6%
- 1 year
- −28.3%
$2.79 · Mkt cap $12.1M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
BioLineRx Ltd.
$2.79 · Mkt cap $12.1M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
BioLineRx Ltd. trades under the ticker BLRX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $12.1M. The last closing price was $2.79, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −28.3%, and −11.6% over the past month. Returns are price returns and exclude dividends.
This page exists because BLRX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.